KELLI PAVLISH: Open Payments
NPI 1255611059 · BELLEVUE, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,191 in 43 payments from 11 companies in 2025. Trend: 2023 $1,185 · 2024 $1,335 · 2025 $1,191
Food & beverage: $1,191
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 10 | $451 |
| ABBVIE INC. | 9 | $234 |
| Xeris Pharmaceuticals, Inc. | 10 | $168 |
| Lilly USA, LLC | 4 | $81 |
| Collegium Pharmaceutical, Inc. | 1 | $77 |
| Otsuka America Pharmaceutical, Inc. | 3 | $59 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| HARMONY BIOSCIENCES LLC | 1 | $27 |
| Phadia US Inc. | 1 | $23 |
| Neuronetics, Inc. | 1 | $21 |
Products named: Auvelity, QULIPTA, Symbravo, RECORLEV, Jornay PM, GVOKE HYPOPEN, REXULTI, UBRELVY.
Industry payments across NE — which companies pay providers there.
